Teva's Copaxone Trial Kicks Off Against Mylan, Sandoz
An attorney for Mylan Pharmaceuticals Inc. told a New York federal judge Wednesday that its generic version of Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone doesn't infringe several Teva patents....To view the full article, register now.
Already a subscriber? Click here to view full article